stockrowCo-Diagnostics, Inc.
CODX Healthcare Medical Devices
Co-Diagnostics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $622,500.00, down 84.1% from fiscal 2024.
- Revenue
- +1.96%
- EPS
- +78.9%
- Free cash flow
- +17.5%
Quarter to June 2026, against a year earlier
Follow CODX
Alert me
Co-Diagnostics, Inc. (CODX) EV/Sales
As of 6 November 2026, Co-Diagnostics, Inc. (CODX) trades at a EV/Sales of −3.6×. Over the past ten years it has ranged from −15.5× (March 2026) to 3,588× (June 2018); the current reading is higher than 14% of that period. That is below the Medical Devices industry median of 2.8× and below the Healthcare sector median of 3.6×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | −8.3× | — |
| FY2024 | −1.8× | — |
| FY2023 | −2.5× | — |
| FY2022 | 0.0× | — |
| FY2021 | 1.7× | (36.43%) |
| FY2020 | 2.7× | (95.89%) |
| FY2019 | 65.5× | (85.17%) |
| FY2018 | 442× | — |
| FY2017 | 0.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 13.5× | — |
| Mar 2026 | −5.6× | — |
| Dec 2025 | −8.3× | — |
| Sep 2025 | 3.1× | — |
| 33 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| ICCM IceCure Medical Ltd. compare | −3.8× |
| CODX Co-Diagnostics, Inc. | −3.6× |
| AIDX 20/20 Biolabs Inc. compare | −0.7× |
| NUVOQ Holdco Nuvo Group D.G Ltd. compare | n/m |
| BJDX Bluejay Diagnostics, Inc. compare | n/m |
| AMIX Autonomix Medical, Inc. compare | n/m |
| NUWE Nuwellis, Inc. compare | 0.0× |
| IVF INVO Fertility, Inc compare | 0.2× |
| ADGM Adagio Medical Holdings, Inc. compare | 30.6× |
| Medical Devices industry median | 2.8× |
| Healthcare sector median | 3.6× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)